MV Capital Management’s BioNTech BNTX Stock Holding History

MV Capital Management’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$94	Buy	+1	New	+$94	﹤0.01%	1227
2026 Q1	–	Sell	-2	Closed	-$191	–	1202
2025 Q4	$191	Buy	+2	New	+$201	﹤0.01%	1036
2022 Q2	–	Sell	-183	Closed	-$31K	–	683
2022 Q1	$31K	Hold	183	–	–	﹤0.01%	272
2021 Q4	$47K	Hold	183	–	–	0.01%	220
2021 Q3	$50K	Hold	183	–	–	0.01%	210
2021 Q2	$41K	Buy	+183	New	+$34.5K	0.01%	208

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

MV Capital Management's BNTX Position: Q2 2026 in Review

MV Capital Management opened a new position in BioNTech (BNTX) in Q2 2026: 1 share worth $94. The stake represents ﹤0.01% of the portfolio and ranks #1227 among its holdings. This is a return to the name: MV Capital Management previously reported a position in BNTX as recently as Q4 2025.

MV Capital Management first reported a position in BNTX in Q2 2021 and has held it in 6 quarters since. The position peaked at $50K in Q3 2021. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

MV Capital Management held 1 share of BioNTech worth $94 as of Q2 2026.
BioNTech was a new MV Capital Management position in Q2 2026.
BioNTech made up ﹤0.01% of MV Capital Management's portfolio in Q2 2026, its #1227 holding.
MV Capital Management first reported a position in BioNTech in Q2 2021 and has held it in 6 quarters since.
MV Capital Management's BioNTech position peaked at $50K in Q3 2021.
283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on MV Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.